4//SEC Filing
Yanai Shlomo 4
Accession 0001209191-21-030815
CIK 0001723128other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 2:10 PM ET
Size
9.4 KB
Accession
0001209191-21-030815
Insider Transaction Report
Form 4
Yanai Shlomo
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-05-06−46,218→ 0 total→ Class A Common Stock (46,218 underlying) - Exercise/Conversion
Class A Common Stock
2021-05-06+46,218→ 53,740 total - Award
Restricted Stock Units
2021-05-05+35,406→ 35,406 total→ Class A Common Stock (35,406 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
- [F3]On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001562645
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 2:10 PM ET
- Size
- 9.4 KB